C/O Hollis Eden Pharmaceuticals, 4435 Eastgate Mall Ste.400, San Diego, CA
Summary
The estimated net worth of Christopher Reading is at least $62.8K dollars as of February 22, 2023. Christopher Reading is the EVP Neuroscience R&D of BIOVIE INC. and owns shares of BIOVIE INC. (BIVI) stock worth about $62.8K.
Insider Transactions Reported by Christopher Reading:
Sym
Company
Class
Transaction
%
Value $
* Price $
Shares
Shares After
Date
Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.